00:22 – What inspired you to shift from traditional pharma into longevity and preventive healthcare?
Umar discusses his 25-year career in pharma, building a Parkinson’s drug, and how turning 50 inspired him to explore proactive health solutions.

01:38 – How do you see proactive disease detection changing health care over the next decade?
He explains the difference between infectious and chronic disease care, highlighting why early detection is critical.

03:42 – What role do partnerships play in scaling RegenaLife’s impact?
Umar outlines how collaborations with clinics and specialists enable earlier treatment of cardiovascular disease and other conditions.

05:20 – How do you balance scientific rigor with speed when bringing new healthcare solutions to market?
He emphasizes the role of AI in de-risking and accelerating testing while enabling scalable business models like telemedicine.

06:57 – What lessons from investment banking and consulting do you apply as CEO today?
Umar reflects on managing complexity, building processes, and creating efficient, client-centered healthcare delivery models.

08:09 – What will be the biggest disruptor in longevity medicine over the next five years?
He predicts at-home diagnostic tools and AI-powered screening will revolutionize how people manage their health.

09:33 – Closing remarks
John thanks Umar for his insights, and Umar reflects on the role of CEO Global in supporting RegenaLife’s rapid growth.